• 10134 Citations
  • 48 h-Index
1991 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2018

  • 10134 Citations
  • 48 h-Index
  • 225 Article
  • 4 Review article
  • 1 Chapter
  • 1 Conference contribution
1 Citation (Scopus)
gemcitabine
Paclitaxel
Pancreatic Neoplasms
Cost-Benefit Analysis
Albumins
gemcitabine
Paclitaxel
Pancreatic Neoplasms
Cost-Benefit Analysis
Albumins

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study

Lazzaro, C., Barone, C., Caprioni, F., Cascinu, S., Falcone, A., Maiello, E., Milella, M., Pinto, C., Reni, M. & Tortora, G., 2018, In : Expert Review of Pharmacoeconomics and Outcomes Research. 18, 4, p. 435-446 12 p.

Research output: Contribution to journalArticle

gemcitabine
Paclitaxel
Pancreatic Neoplasms
Cost-Benefit Analysis
Albumins

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma

Reni, M., Zanon, S., Balzano, G., Passoni, P., Pircher, C., Chiaravalli, M., Fugazza, C., Ceraulo, D., Nicoletti, R., Arcidiacono, PG., Macchini, M., Peretti, U., Castoldi, R., Doglioni, C., Falconi, M., Partelli, S. & Gianni, L., 2018, In : European Journal of Cancer. 102, p. 95-102 8 p.

Research output: Contribution to journalArticle

gemcitabine
Cisplatin
Adenocarcinoma
Disease-Free Survival
Survival

Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma

Zhen, DB., Coveler, A., Zanon, S., Reni, M. & Chiorean, EG., 2018, In : Seminars in Oncology. 45, 3, p. 107-115 9 p.

Research output: Contribution to journalArticle

Adenocarcinoma
Biomarkers
Hyaluronic Acid
Neoplasms
DNA Mismatch Repair